Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 6
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
French National Institute of Health and Medical Research, Medical Devices Deals, 2012 to YTD 2018 12
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deal Details 18
Venture Financing 18
Therachon Raises USD60 Million in Mezzanine Financing 18
ILiAD Biotech Raises USD0.6 Million in Venture Financing 20
Step Pharma Raises Additional USD10.1 Million in Series A Financing 21
ILiAD Biotech Raises USD4.7 Million in Financing 23
ILiAD Biotech Raises USD1.2 Million in Venture Financing 24
Therachon Raises Additional USD5 Million in Series A Financing Round 25
ILiAD Biotech Raises USD0.5 Million in Venture Financing 27
ILiAD Biotech Raises USD1 Million in Venture Financing 28
Inception IBD Raises USD14.1 Million in Series A Financing 29
ILiAD Biotech Raises USD0.6 Million in Venture Financing 30
Therachon Raises USD35 Million in Series A Financing 31
Eyevensys Secures Venture Funding 32
Sensorion Raises USD4.6 Million in Venture Financing 33
AAVLife Raises US$12 Million In Series A Financing 34
Aelis Farma Raises USD1.7 Million in Venture Financing 35
Inotrem Raises US$25 Million In Series A Financing 36
Hemarina Raises US$8 Million In Series B Financing 38
Eyevensys Raises US$2 Million In First Round Of Financing 39
Partnerships 40
Telix Pharma Enters into Research Agreement with INSERM and ARRONAX 40
Genisphere Enters into Agreement with Inserm 41
TxCell Enters into R&D Agreement with Inserm Transfert 42
Evotec Enters into Research Agreement with Inserm Transfert 43
Pierre Fabre Medicament Partners with Inserm Transfert 44
AstraZeneca Enters into Research Agreement with Inserm 45
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 46
Mifcare Enters into Agreement with Inserm 47
DBV Technologies Enters Into Research Agreement With Inserm For Viaskin 48
Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 50
Covance Enters Into Co-Development Agreement With Inserm Transfert And Inserm Transfert Initiative 52
Licensing Agreements 54
OSE Immunotherapeutics Enters into Option Agreement with Inserm Transfert 54
Stimunity Enters into Licensing Agreement with Inserm Transfert and Institut Curie 55
ProQR Therapeutics Signs License Agreement with Inserm Transfert and Assistance-Publique-Hopiteaux de Paris 56
TargEDys Enters into Licensing Agreement with Inserm Transfert, University of Rouen and Rouen University Hospital 57
ElsaLys Biotech Enters into Licensing Agreement with Inserm Transfert 58
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 59
Brainvectis Enters into Licensing Agreement with INSERM 60
ProGeLife Enters into Licensing Agreement with University of Bordeaux and INSERM Transfert 61
Inserm Transfert Enters into Licensing Agreement with HalioDx 62
Ultragenyx Pharma Enters into Licensing Agreement with Inserm Transfert and Institut du Cerveau et de la Moelle Epiniere 63
IntegraGen Enters into Licensing Agreement with Inserm 65
AAVLife Amends Licensing Agreement with Inserm Transfert 66
Inotrem Enters into Licensing Agreement with University of Lorraine and INSERM 67
Acticor Biotech Enters into Licensing Agreement with Inserm Transfert 68
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 69
GlaxoSmithKline Enters Into Licensing Agreement With Inserm Transfert For Monoclonal Antibodies 70
Anagenesis Biotech Enters into Licensing Agreement with Inserm Transfert and AFM 71
GenSight Biologics Enters into Licensing Agreement with AFM, Genethon and Inserm Transfert 72
GenSight Biologics Enters into Licensing Agreement with Inserm Transfert 74
ILiAD Biotech Enters Into Licensing Agreement With Inserm Transfert And Institut Pasteur De Lille For Bordetella Pertussis Vaccine Technology 76
Equity Offering 77
Horama Spin off from Inserm Transfert 77
French National Institute of Health and Medical Research – Key Competitors 78
French National Institute of Health and Medical Research – Key Employees 79
French National Institute of Health and Medical Research – Locations And Subsidiaries 80
Head Office 80
Other Locations & Subsidiaries 80
Affiliate 80
Recent Developments 81
Government and Public Interest 81
Sep 03, 2018: Gene-hunters make sense of a new immune disease 81
Aug 31, 2018: Novel brain network linked to chronic pain in Parkinson’s disease 83
May 02, 2018: Discovery of a first genetic cause of Whipple’s disease 84
Apr 26, 2018: Discovery of a future therapy for hemoglobinopathies 85
Dec 20, 2017: NORD Awards Five New Grants for Rare Disease Research 86
Other Significant Developments 87
Aug 20, 2018: Bioengineered tooth replacement opens doors to new therapies 87
Appendix 88
Methodology 88
About GlobalData 88
Contact Us 88
Disclaimer 88
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Key Facts 2
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
French National Institute of Health and Medical Research, Deals By Therapy Area, 2012 to YTD 2018 10
French National Institute of Health and Medical Research, Medical Devices Deals, 2012 to YTD 2018 12
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Therachon Raises USD60 Million in Mezzanine Financing 18
ILiAD Biotech Raises USD0.6 Million in Venture Financing 20
Step Pharma Raises Additional USD10.1 Million in Series A Financing 21
ILiAD Biotech Raises USD4.7 Million in Financing 23
ILiAD Biotech Raises USD1.2 Million in Venture Financing 24
Therachon Raises Additional USD5 Million in Series A Financing Round 25
ILiAD Biotech Raises USD0.5 Million in Venture Financing 27
ILiAD Biotech Raises USD1 Million in Venture Financing 28
Inception IBD Raises USD14.1 Million in Series A Financing 29
ILiAD Biotech Raises USD0.6 Million in Venture Financing 30
Therachon Raises USD35 Million in Series A Financing 31
Eyevensys Secures Venture Funding 32
Sensorion Raises USD4.6 Million in Venture Financing 33
AAVLife Raises US$12 Million In Series A Financing 34
Aelis Farma Raises USD1.7 Million in Venture Financing 35
Inotrem Raises US$25 Million In Series A Financing 36
Hemarina Raises US$8 Million In Series B Financing 38
Eyevensys Raises US$2 Million In First Round Of Financing 39
Telix Pharma Enters into Research Agreement with INSERM and ARRONAX 40
Genisphere Enters into Agreement with Inserm 41
TxCell Enters into R&D Agreement with Inserm Transfert 42
Evotec Enters into Research Agreement with Inserm Transfert 43
Pierre Fabre Medicament Partners with Inserm Transfert 44
AstraZeneca Enters into Research Agreement with Inserm 45
Antitope Extends Research Agreement with ANRS, INSERM and Baylor Research Institute 46
Mifcare Enters into Agreement with Inserm 47
DBV Technologies Enters Into Research Agreement With Inserm For Viaskin 48
Roche, ANRS, Baylor Researh Institute And Inserm Transfert Enter Into Co-Development Agreement For Therapeutic Vaccines 50
Covance Enters Into Co-Development Agreement With Inserm Transfert And Inserm Transfert Initiative 52
OSE Immunotherapeutics Enters into Option Agreement with Inserm Transfert 54
Stimunity Enters into Licensing Agreement with Inserm Transfert and Institut Curie 55
ProQR Therapeutics Signs License Agreement with Inserm Transfert and Assistance-Publique-Hopiteaux de Paris 56
TargEDys Enters into Licensing Agreement with Inserm Transfert, University of Rouen and Rouen University Hospital 57
ElsaLys Biotech Enters into Licensing Agreement with Inserm Transfert 58
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 59
Brainvectis Enters into Licensing Agreement with INSERM 60
ProGeLife Enters into Licensing Agreement with University of Bordeaux and INSERM Transfert 61
Inserm Transfert Enters into Licensing Agreement with HalioDx 62
Ultragenyx Pharma Enters into Licensing Agreement with Inserm Transfert and Institut du Cerveau et de la Moelle Epiniere 63
IntegraGen Enters into Licensing Agreement with Inserm 65
AAVLife Amends Licensing Agreement with Inserm Transfert 66
Inotrem Enters into Licensing Agreement with University of Lorraine and INSERM 67
Acticor Biotech Enters into Licensing Agreement with Inserm Transfert 68
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 69
GlaxoSmithKline Enters Into Licensing Agreement With Inserm Transfert For Monoclonal Antibodies 70
Anagenesis Biotech Enters into Licensing Agreement with Inserm Transfert and AFM 71
GenSight Biologics Enters into Licensing Agreement with AFM, Genethon and Inserm Transfert 72
GenSight Biologics Enters into Licensing Agreement with Inserm Transfert 74
ILiAD Biotech Enters Into Licensing Agreement With Inserm Transfert And Institut Pasteur De Lille For Bordetella Pertussis Vaccine Technology 76
Horama Spin off from Inserm Transfert 77
French National Institute of Health and Medical Research, Key Competitors 78
French National Institute of Health and Medical Research, Key Employees 79
French National Institute of Health and Medical Research, Subsidiaries 80
French National Institute of Health and Medical Research, Affiliate 80
List of Figures
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
French National Institute of Health and Medical Research, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
French National Institute of Health and Medical Research, Medical Devices Deals, 2012 to YTD 2018 12